| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/09/2006 | WO2005117931A3 Glut1 transporters expressed in cancer cells |
| 03/09/2006 | WO2005110477A3 Combination therapies for cancer and proliferative angiopathies |
| 03/09/2006 | WO2005102387A3 Therapeutic use of anti-cs1 antibodies |
| 03/09/2006 | WO2005099754A3 Maytansinoid analogs as antitumor agents |
| 03/09/2006 | WO2005089794A3 Combination vaccines with low dose of hib conjugate |
| 03/09/2006 | WO2005076696A3 Pneumolysin derivatives |
| 03/09/2006 | WO2005054258A3 New class of gamma delta t cells activators and use thereof |
| 03/09/2006 | WO2005052004A3 Compositions comprising polypeptides |
| 03/09/2006 | WO2004071446A3 Immune complexes |
| 03/09/2006 | US20060053516 Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS |
| 03/09/2006 | US20060053501 Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses |
| 03/09/2006 | US20060052951 Methods and compositions for cancer treatment relating to BRCA1 BRCT domain recognition of phosphorylated BACH1 |
| 03/09/2006 | US20060052593 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions |
| 03/09/2006 | US20060052585 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052295 native staphylococcal enterotoxin or streptococcal pyrogenic exotoxin protein, stimulates T cell mitogensis; fusion proteins; carcinomas; combination therapy |
| 03/09/2006 | US20060051877 Fibronectin biopolymer marker indicative of insulin resistance |
| 03/09/2006 | US20060051839 DNA expression vectors and methods of use |
| 03/09/2006 | US20060051836 Molecules for disease detection and treatment |
| 03/09/2006 | US20060051823 specific antigenic proteins and peptides unique to Treponema pallidum; diagnosis of syphilis; immunoassay of acidic repeat protein/immunogens |
| 03/09/2006 | US20060051822 Methods for detecting Bacillus thuringiensis cryET33 and cry ET34 polypeptides |
| 03/09/2006 | US20060051759 Compositions and methods relating to breast specific genes and proteins |
| 03/09/2006 | US20060051757 Diagnostic and therapeutic use of ensadin-0477 gene and protein for neurodegenerative diseases |
| 03/09/2006 | US20060051754 Transporter selectively transporting sulfate conjugate and its gene |
| 03/09/2006 | US20060051746 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 03/09/2006 | US20060051742 Novel assay for the separation and quantification of hemagglutinin antigens |
| 03/09/2006 | US20060051381 Cytokine antagonists for neurological and neuropsychiatric disorders |
| 03/09/2006 | US20060051380 Methods and compositions for the targeting of a systemic immune response to specific organs or tissues |
| 03/09/2006 | US20060051379 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis |
| 03/09/2006 | US20060051378 Mucosal vaccines with chitosan adjuvant and meningococcal antigens |
| 03/09/2006 | US20060051377 Stretch mark treatment |
| 03/09/2006 | US20060051376 Remedy for fibromyalgia |
| 03/09/2006 | US20060051375 Rabbit skin comprising biological active substances and its use |
| 03/09/2006 | US20060051374 Compositions and methods for mucosal vaccination |
| 03/09/2006 | US20060051373 Particle-bound human immunodeficiency virus envelope glycoproteins and related compositions and methods |
| 03/09/2006 | US20060051372 Antigenic compounds |
| 03/09/2006 | US20060051371 immunogenic non-haemolytic strain of Actinobacillus pleuropneumoniae which is modified in segment of apxIA gene and optionally in segment of apxIIA gene that encodes transmembrane domain of Apx haemolytic and cytolytic exotoxins; comprises also strains and attenuated live vaccine porcine pleuorpneumonia |
| 03/09/2006 | US20060051370 Microorganisms for therapy |
| 03/09/2006 | US20060051369 ADAR1 antiviral pathway |
| 03/09/2006 | US20060051368 Herpes simplex virus mutations |
| 03/09/2006 | US20060051367 Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences |
| 03/09/2006 | US20060051366 Use of soluble CD26 as inhibitor of angiogenesis and inflammation |
| 03/09/2006 | US20060051365 Immunogenic composition |
| 03/09/2006 | US20060051364 Purified salivary Lu. longipalpis polypeptides, and polynucleotides encoding these; vectors and host cells; inducing an immune response to sand fly saliva; diagnosing or preventing Leishmaniasis; genetic engineering |
| 03/09/2006 | US20060051363 Protein inducing cell death of helicobacter pylori |
| 03/09/2006 | US20060051362 Antigens for actinobacillus pleuropneumoniae and methods thereof |
| 03/09/2006 | US20060051361 Vaccine against Streptococcus pneumoniae |
| 03/09/2006 | US20060051360 Non-denatured, recombinant human immunodeficiency virus (HIV) Tat that is free of bacterial RNA and endotoxin; |
| 03/09/2006 | US20060051359 Recombinant immunotoxin and use in treating tumors |
| 03/09/2006 | US20060051357 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and or a mtor inhibitor |
| 03/09/2006 | US20060051356 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 03/09/2006 | US20060051355 Methods and means for the treatment of immune-related diseases |
| 03/09/2006 | US20060051354 Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof |
| 03/09/2006 | US20060051353 Methods and compositions to evaluate antibody treatment response |
| 03/09/2006 | US20060051352 CEA binding agents and compositions to reverse CEA-mediated tumorigenic effects on human cancer cells, restore sensitivity to drug induced apoptosis and uses thereof |
| 03/09/2006 | US20060051351 ErbB4 receptor-specific neuregulin related ligands and uses therefor |
| 03/09/2006 | US20060051350 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (GITR or TNFRSF18) |
| 03/09/2006 | US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/09/2006 | US20060051348 Method of producing a plurality of isolated antibodies to a plurality of cognate antigens |
| 03/09/2006 | US20060051347 Process for concentration of antibodies and therapeutic products thereof |
| 03/09/2006 | US20060051346 Humanized anti-CD4 antibody with immunosuppressive properties |
| 03/09/2006 | US20060051345 Method for treating multiple sclerosis |
| 03/09/2006 | US20060051344 Antibody and utilization of the same |
| 03/09/2006 | US20060051343 Preventives remedies for bone and joint diseases |
| 03/09/2006 | US20060051342 Carrier having immobilized antigens or antibodies and method of manufacturing thereof |
| 03/09/2006 | US20060051341 Administering about 1 unit to about 3,000 units of a native botulinum toxin subcutaneously, intramuscularly, subdermally, intradermally or transdermally to a buttock of a patient having a buttock deformity |
| 03/09/2006 | US20060051331 Optimization of transgene expression in mammalian cells |
| 03/09/2006 | US20060051325 Isolation and use of solid tumor stem cells |
| 03/09/2006 | US20060051324 Pharmaceutical composition for inducing an immune response in a human or animal |
| 03/09/2006 | US20060051292 Useful to form complexes having an affinity to targets of interest; verotoxin subunit B |
| 03/09/2006 | US20060051265 Apparatus and method for sorting microstructures in a fluid medium |
| 03/09/2006 | CA2591532A1 Nucleic acid sequences encoding proteins capable of associating into a virus-like particle |
| 03/09/2006 | CA2578995A1 2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use |
| 03/09/2006 | CA2578588A1 Improvements relating to meningococcal outer membrane vesicles |
| 03/09/2006 | CA2578403A1 Recombinant mva viruses expressing clade a/g, clade b, and clade c modified hiv, gag and pol genes |
| 03/09/2006 | CA2578147A1 Modified hiv-1 envelope proteins |
| 03/09/2006 | CA2578014A1 Domains and epitopes of meningococcal protein nmb1870 |
| 03/09/2006 | CA2577920A1 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 03/09/2006 | CA2577918A1 Vaccine composition against hepatitis c virus |
| 03/09/2006 | CA2577702A1 New polymorphic form of inulin and uses thereof |
| 03/09/2006 | CA2577678A1 Humanized anti-beta7 integrin subunit antibodies and uses therefor |
| 03/09/2006 | CA2577470A1 Fiber-modified adenoviral vectors for enhanced transduction of tumor cells |
| 03/09/2006 | CA2576798A1 Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use |
| 03/09/2006 | CA2575675A1 Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin |
| 03/09/2006 | CA2570735A1 Treatment of hiv infection by t-cell modulation |
| 03/08/2006 | EP1632564A1 Vaccine against severe accute respiratory syndrome causing coronavirus (SARS-CoV) |
| 03/08/2006 | EP1632499A2 Gene sequences amplified in tumours and their diagnostic uses |
| 03/08/2006 | EP1632248A1 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness |
| 03/08/2006 | EP1632247A1 Nucleic acid sequences encoding FMDV proteins capable of associating into a virus-like particle |
| 03/08/2006 | EP1632242A2 Novel method for down-regulation of amyloid |
| 03/08/2006 | EP1631823A2 NOVEL REGULATORY MECHANISMS OF NF-kappaB |
| 03/08/2006 | EP1631590A2 Humanized antibodies to interferon alpha receptor-1 (ifnar-1) |
| 03/08/2006 | EP1631585A1 Tumor antigens for prevention and/or treatment of cancer |
| 03/08/2006 | EP1631581A2 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections |
| 03/08/2006 | EP1631315A2 Antibodies which bind human cxcr3 |
| 03/08/2006 | EP1631314A2 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions |
| 03/08/2006 | EP1631313A2 Combination therapy for b cell disorders |
| 03/08/2006 | EP1631311A2 Humanized anti-ccr2 antibodies and methods of use |
| 03/08/2006 | EP1631310A1 Cells used as carriers for bacteria |
| 03/08/2006 | EP1631264A1 Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen |